[Inhibition of CD4+ CD25+ regulatory T cells in chronic hepatitis B patients].
Henghui Zhang(Capital Medical University), Hongsong Chen(Inner Mongolia University for Nationalities), Hui Ma(Fudan University), Fang Guo, Ran Fei(Peking University), Cong Xu(Tongji Hospital), Lai Wei(Nanjing University of Finance and Economics)
PubMed
February 26, 2008
Cited by 4
Related Papers
New progress in the pharmacology of protocatechuic acid: A compound ingested in daily foods and herbs frequently and heavily
|Pharmacological Research|2020|301
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
|Journal of Experimental & Clinical Cancer Research|2015|271
Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease
|Frontiers in Immunology|2022|122
The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease
|Journal of Hepatology|2021|118